Advances in cancer nanomedicine

Journal of the Indian Institute of Science

Volumn 92, Issue 2, 2012, Pages 187-218

  Rani, Divya ^a   Somasundaram, Vijay Harish ^a   Nair, Shanti ^a   Koyakutty, Manzoor ^a  

^a AMRITA SCHOOL OF ARTS AND SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ABNORMAL CELL DIVISION; ADVERSE SIDE EFFECTS; BLOOD SUPPLY; CARBON NANOSTRUCTURES; CYTOTOXIC DRUGS; DRUG RESISTANCE; GENETIC ALTERATIONS; GROWTH CONTROL; INORGANIC NANOPARTICLE; MAGNETIC HYPERTHERMIA; PHOTOTHERMAL THERAPY; POLYMERIC NANOPARTICLES; RADIO FREQUENCIES; SCIENTIFIC ADVANCES; SECOND GENERATION; TARGETED CANCER THERAPY;

BIOLOGY; DENDRIMERS; DISEASES; DRUG THERAPY; LIPOSOMES; MEDICAL NANOTECHNOLOGY; NANOMAGNETICS; NANOPARTICLES; ONCOLOGY;

HYPERTHERMIA THERAPY;

EID: 84864742444     PISSN: 09704140     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (191)

1. Hanan, D., Weinberg, R. A. "Hallmarks of cancer: The next generation", Cell, doi: 10.1016.2011.02.013, 2011.
2. Lemmon, M. A., Schlessinger, J. "Cell signaling by receptor tyrosine Kinases", Cell, 141, pp. 1117-1134, 2010.
3. Witsch, E., Sela, M., Yarden, Y. "Roles for growth factors in cancer Progression", Physiology (Bethesda) 25(2), pp. 85-101, 2010.
4. Cheng, N., Chytil, A., Shyr, Y., Joly, A., Moses, H. L. "Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion", Mol. Cancer Res. 6(10), pp. 1521-1533, 2008.
5. Bhowmick, N. A., Neilson, E. G., Moses, H. L. "Stromal fibroblasts in cancer initiation and progression", Nature, 432(7015), pp. 332-337, 2004. (Pubitemid 39551661)
6. Fedi, P., Tronick, S. R., Aaronson, S. A. "Growth factors. In Cancer Medicine", J. F. Holland, R. C. Bast, D. L. Morton, E. Frei, Kufe, D. W., Weichselbaum, R. R., eds. (Baltimore, MD: Williams and Wilkins), pp. 41-64.
7. Lukashev, M. E., Werb, Z. "ECM signaling: orchestrating cell behaviour and misbehavior", Trends Cell Biol. 8(11), pp. 437-441, 1998. (Pubitemid 28529716)
8. Giancotti, F. G., Ruoslahti, E. "Integrin signaling", Science, 285(5430), pp. 1028-1032, 1999.
9. Jiang, B. H., Liu, L. Z. "PI3K/PTEN signaling in angiogenesis and tumorigenesis", Adv. Cancer Res. 102, pp. 19-65, 2009.
10. Sudarsanam, S., Johnson, D. E. "Functional consequences of mTOR inhibition", Curr. Opin. Drug Discov. Devel. 13(1), pp. 31-40, 2010.
11. Lowe, S. W., Cepero, E., Evan, G. "Intrinsic tumor suppression", Nature 432, pp. 307-315, 2004.
12. Adams, J. M., Cory, S. "The Bcl-2 apoptotic switch in cancer development and therapy", Oncogene, 26(9), 1324-1337, 2007. (Pubitemid 46328466)
13. Junttila, M. R., Evan, G. I. "p53-a Jack of all trades but master of none", Nat. Rev. Cancer, 9, pp. 821-829, 2009.
14. Hayflick, L. "Mortality and immortality at the cellular level, A review", Biochemistry, 62(11), pp. 1180-1190, 1997. (Pubitemid 127665905)
15. Baeriswyl, V., Christofori, G. "The angiogenic switch in carcinogenesis", Semin. Cancer Biol. 19(5), pp. 329-337, 2009.
16. Volpert, O. V., Dameron, K. M., Bouck, N. "Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenecity", Oncogene 14(12), pp. 1495-1502, 1997. (Pubitemid 27182439)
17. Berx, G., van Roy F. "Involvement of members of the cadherin superfamily in cancer", Cold Spring Harb. Perspect. Biol., 1, pp. a003129, 2009.
18. Fogar, P., Basso, D., Pasquali, C, De Paoli, C., Sperti, C., Roveroni, G., Pedrazzoli, G., Plebani, M. "Neural cell adhesion molecule (N-CAM) in gastrointestinal neoplasias", Anticancer Res. 17(2B), pp. 1227-1230, 1997.
19. Talmadge, J. E., Fidler, I. J. "AACR centennial series: the biology of cancer metastasis: historical perspective", Cancer Res. 70(14), pp. 5649-5669, 2010.
20. Kateb, B., Chiu, K., Black, K. L., Yamamoto, V., Khalsa, B., Ljubimova, J. Y., Ding, H., Patil, R., Portilla-Arias, J. A., Modo, M., Moore, D. F., Farahani, K., Okun, M. S., Prakash, N., Neman, J., Ahdoot, D., Grundfest, W., Nikzad, S., Heiss, J. D. "Nanoplatforms for constructing new approaches to cancer treatment, imaging and drug delivery: what should be the policy?", Neuroimage, 54, pp. S106-S124, 2011.
21. Scheinber, D. A., Villa, C. H., Escorcia, F. E., McDevitt, M. R. "Conscripts of the infinite armada: systemic cancer therapy using nanomaterials", Nature Reviews, 7, pp. 266-276, 2010.
22. Chithrani, B. D., Ghazani, A. A., Chan, W. C. "Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells", Nano Lett. 6(4), pp. 662-668, 2006.
23. Jiang, W., Kim, B. Y., Rutka, J., Chan, W. C. "Nanoparticlemediated cellular response is size-dependent", Nat. Nanotechnol. 3, pp. 145-150, 2008.
24. Poland, C. A., Duffin, R., Kinloch, I., Maynard, A., Wallace, W. A., Seaton, A., Stone, V., Brown, S., MAcNee, W., Donaldson, K. "Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study", Nat. Nanotechnol. 3, pp. 423-428, 2008.
25. Choi, H. S., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Ipe, B. I., Bawendi, M. G., Frangioni, J. V. "Renal clearance of quantum dots", Nat. Biotechnol. 25, pp. 1165-1170, 2007. (Pubitemid 47538116)
26. Burns, A. A., Vider, J., Ow, H., Herz, E., Penate-Medina, O., Baumgart, M., Larson, S. M., Wiesner, U., Bradburry, M. "Fluorescent silica nanoparticles with efficient urinary excretion for Nanomedicine", Nano Lett. 9(1), pp. 442-448, 2009.
27. Fox, M. E., Szoka F. C., Frechet J. M. "Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture", Acc. Chem. Res. 42, pp. 1141-1151, 2009.
28. Zhang, K., Fang, H., Chen, Z., Taylor, J. S., Wooley, K. L. "Shape effects of nanoparticles conjugated with cell-penetrating peptides (HIV Tat PTD) on CHO cell uptake", Bioconjug. Chem. 19(9), pp. 1880-1887, 2008.
29. Gratton, S. E., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., Desimone, J. M. "The effect of particle design on cellular internalization pathways", Proc. Natl. Acad. Sci. USA 105, pp. 11613-11618, 2008.
30. Villa, C., McDevitt, M. R., Escorcia, F. E., Rey, D. A., Bergkvist, M., Batt, C. A., Scheinber, D. A. "Synthesis and bio distribution of oligonucleotide-functionalized, tumor-targetable carbon nanotubes", Nano Lett. 8(12), pp. 4221-4228, 2008.
31. Verma, A., Uzun, O., Hu, Y., Hu, Y., Han, H, Watson, N., Chen, S., Irvine, D. J., Stellacci, F. "Surface-structure-regulated cell membrane penetration by monolayer-protected nanoparticles", Nat. Mater. 7, pp. 588-595, 2008.
32. Kobayashi, H., Le, N., Kim, I. S., Kim, M. K., Pie, J. E., Drumm, D., Paik, D. S., Waldmann, T. A., Paik, C. H., Carrasquillo, J. A. "The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points", Cancer Res. 59, pp. 422-430, 1999. (Pubitemid 29048878)
33. Faure, A. C., Dufort, S., Josserand, V., Perriat, P., Coll, J. L., Roux, S., Tillement, O. "Control of the in vivo bio distribution of hybrid nanoparticles with different poly(ethylene glycol) coatings", Small 5(22), pp. 2565-2575, 2009.
34. Gotthardt, M., Van Eard Vismale, J., Oyen, W. J., De Jong, M., Zhang, H., Rolleman, E., Maecke, H. R., Behe, M., Boerman, O. "Indication for different mechanisms of kidney uptake of radio labeled Peptides", J. Nucl. Med. 48(4), pp. 596-601, 2007. (Pubitemid 47571416)
35. Suh J., Choy, K., Lai, S. K., Suk, J. S., Tang, B., Prabhu, S., Hanes, J. "PEGylation of nanoparticles improves their cytoplasmic transport", Int J Nanomedicine, 2(4), pp. 735-741, 2007.
36. Arruebo, M., Valladares, M., Gonzallez-Fernandez, A. "Antibody conjugated nanoparticles of biomedical application", Journal of Nanomaterials, doi: 10.1155/2009/439389, 2009.
37. Portilla-Arias, J. A., Garcia-Alvarez, M., Galbis, J. A., Munoz-Guerra, S. "Biodegradable nanoparticles of partially methylated fungal poly (beta-L-malic acid) as a novel protein delivery carrier", Macromol. Biosci. 8(6), pp. 551-559, 2008.
38. Barratt, G. "Colloidal drug carriers: achievements and perspectives", Cellular and Molecular Life Sciences 60(1), pp. 21-37, 2003. (Pubitemid 36223115)
39. Gilding, D. K., Reed, A. M. "Biodegradable polymers for use in surgery-polyglycolic/poly (lactic acid) homo-and copolymers: 1", Polymer 20(12), pp. 1459-1464, 1979. (Pubitemid 10435422)
40. Lockman, P. R., Mumper, R. J., Khan, M. A., Allen, D. D. "Nanoparticle technology for drug delivery across the blood-brain barrier", Drug Dev. Ind. Pharm. 28(1), pp. 1-13, 2002. (Pubitemid 34279373)
41. Kateb, B., Chiu, K., Black, K. L., Yamamoto, V., Khalsa, B., Ljubimova, J. Y., Ding, H., Patil, R., Portilla-Arias, J., Modo, M., Moore, D. F., Farahani, K., Okun, M. S., Prakash, N., Neman, J., Ahdoot, D., Grundfest, W., Nikzad, S., jheiss, J. D. "Nanoplatforms for constructing new approaches to cancer treatment, imaging and drug delivery: what should be the policy?", Neuroimage, 54, S(1), pp. 106-124, 2011.
42. D. Bissett, D., Cassidy, de Bono, J. S., Muirhead, F., Main, M., Robson, L., Fraier, D.,Magne, M. L., Pellizzoni, C., Porro, M. G., Spinelli, R., Speed, W., Twelves, C. "Phase I and pharmacokinetic (PK) study of MAG-CPT (PNU 166148): a polymeric derivativeof camptothecin (CPT)", Br. J. Cancer 91(1), 2004, 50-55. (Pubitemid 39013044)
43. Boddy, A. V., Plummer, E. R., Todd, R., Sludden, J., Griffin, M., Robson, L., Cassidy, J., Bissett, D., Bernareggi, A., Verrill, M. W., Calvert, A. H. "A phase I and pharmacokinetic study of paclitaxel poliglumex (XYOTAX), investigating both 3-weekly and 2-weeklySchedules", Clin. Cancer Res. 11(21), 2005, 7834-7840. (Pubitemid 41611628)
44. Vasey, P. A., Kaye, S. B., Morrison, R., Twelves, C., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., Burtles, S., Fraier, D., Frigerio, E., Cassidy, J. "Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl) methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates", Cancer Research Campaign Phase I/II Committee, Clin. Cancer Res. 5, 1999, 83-94. (Pubitemid 29045181)
45. Eliaz, R. E, Nir, S. Marty, C., Szoka, F. C., Jr. "Determination and modeling of kinetics of cancer cell killing by doxorubicin and doxorubicin encapsulated in targeted liposomes", Cancer Res, 64, 2004, 711-8. (Pubitemid 38120914)
46. Wagner, V., Dullaart, A., Bock, A. K., Zweck, A. "The emerging nanomedicine landscape", Nat Biotechnol, 24, 2006, 1211-7. (Pubitemid 44564760)
47. Federman, N., Denny, C. T. "Targeting liposomes toward novel pediatric anticancer therapeutics", Pediatr Res, 67(5), 2010, 514-519.
48. Mangala, L. S., Han, H. D., Lopez-Berestein, G., Sood, A. K. "Liposomal siRNA for ovarian cancer", Methods Mol Biol 555, 2009, 29-42.
49. Tekade, R. K., Kumar, P. V., Jain, N. K. "Dendrimers in oncology: an expanding Horizon", Chem. Rev. 109(1), 2009, 49-87.
50. Bharali, D. J., Khalil, M., Gurbuz, M., Simone, T. M., Mousa, S. A. "Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers", Int. J. Nanomedicine 4(1), 2009, 1-7.
51. Gillies, E. R., Frechet, J. M. J. "Dendrimers and dendritic polymers in drug delivery", Drug Discov. Today 10, pp. 35, 2005.
52. Talanov, V. S., Regino, C. A., Kobayashi, H., Bernardo, M., Choyke, P. L., Brechbiel, M. W. "Dendrimer-based nanoprobe for dual modality magnetic resonance and fluorescence imaging", Nano Lett. 6(7), 2006, 1459-1463. (Pubitemid 44195328)
53. Shi, X., Wang, S., Meshinchi, S., Van Antwerp, M. E., Bi, X., Lee, I., Baker, J. R. "Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging", Small 3(7), 2007, 1245-1252. (Pubitemid 47114383)
54. Kwon, G. S., Naito, S., Kataoka, K., Yokoyama, M., Sakurai, Y., Okano, T. "Block copolymer micelles as vehicles for hydrophobic Drugs", Colloids Surf B Biointerfaces, 16, 1994, 429-434.
55. Adams, M. L., Lavasanifar, A., Kwon G. S. "Amphiphilic block copolymers for drug delivery", J Pharm Sci., 92(7), 2003, 1343-55. (Pubitemid 36792748)
56. Mikhail, A. S., Allen, C. "Block copolymer micelles for delivery of cancer therapy: Transport at the whole body, tissue and cellular levels", J Control Release, 2009, 138(3), pp. 214-223.
57. Djordjevic, J., Michniak, B., Uhrich, K. E. "Amphiphilic star-like macromolecules as novel carriers for topical delivery of nonsteroidal anti-inflammatory drugs", AAPS pharm Sci 5(4), E26, 2003.
58. Trubetskoy, V. S. "Polymeric micelles as carriers of diagnostic agents", Adv Drug Deliv Rev. 1999, 37:81-8. (Pubitemid 29164501)
59. Matsumura Y. "Polymeric micellar delivery systems in oncology", Jpn J Clin Oncol. 2008, 38(12), 793-802.
60. Nakajima, T. E., Yasunaga, M., Kano, Y., Koizumi, F., Kato, K., Hamaguchi, T. "Synergistic antitumor activity of the novel SN-38-incorporating polymeric micelles, NK012, combined with 5-fluorouracil in a mouse model of colorectal cancer, as compared with that of irinotecan plus 5-fluorouracil", Int J Cancer, 2008, 122(9), 2148-53. (Pubitemid 351441208)
61. Hamaguchi, T., Matsumura, Y., Suzuki, M., Shimizu, K., Goda, R., Nakamura, I. "NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel", Br J Cancer, 92, 2005, 1240-6. (Pubitemid 40604398)
62. Lee, K. S., Chung, H. C., Im, S. A., Park, Y. H., Kim, C. S., Kim, S. B. "Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer", Breast Cancer Res Treat, 108(2), 2008, 241-50. (Pubitemid 351311357)
63. Kim, D. W., Kim, S. Y., Kim, H. K., Kim, S. W., Shin, S. W., Kim. "Multicenter phase II trial of Genexol-PM, a novel Cremophorfree, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-smallcell lung cancer", Ann Oncol, 18(12), 2007, 2009-14.
64. Mahmud, A, Xiong, X. B., Aliabadi, H. M., Lavasanifar, A. "Polymeric micelles for drug targeting", J Drug Target, 15(9), 2007, 553-84. (Pubitemid 350031081)
65. Torchilin, V. P. "Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery", Biopolymers, 90(5), 2008, 604-10.
66. Kabanov, A. V., Chekhonin, V. P., Alakhov, V. Y., Batrakova, E. V., Lebedev, A. S., Melik-Nubarov, N. S. "The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting", FEBS Lett, 258(2), 1989, 343-5. (Pubitemid 20001084)
67. Vega, J., Ke, S., Fan, Z., Wallace, S., Charsangavej, C., Li, C. "Targeting doxorubicin to epidermal growth factor receptors by site-specific conjugation of C225 to poly(Lglutamic acid) through a polyethylene glycol spacer", Pharm Res, 20(5), 2003, 826-32. (Pubitemid 36515318)
68. Leamon, C. P., Reddy, J. A. "Folate-targeted chemotherapy", Adv Drug Deliv Rev., 56(8), 2004, 1127-41.
69. Nasongkla, N., Shuai, X., Ai, H., Weinberg, B. D., Pink, J., Boothman D. A. "cRGD-functionalized polymer micelles for targeted doxorubicin delivery", Angew Chem Int Ed Engl, 43(46), 2004, 6323-7. (Pubitemid 40029462)
70. Cormode, D. P., Jarzyna, P. A, Mulder, W. J., Fayad, Z. A. "Modified natural nanoparticles as contrast agents for medical imaging", Adv Drug Deliv Rev, 62(3), 2010, 329-338.
71. Liu, Z., Fan, A. C., Rakhra, K. "Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy", Angew Chem Int Ed Eng, 48(41), 2009, 7668-7672.
72. Xu, Y., Wen, Z., Xu Z. "Chitosan nanoparticles inhibit the growth of human hepatocellular carcinoma xenografts through an anti angiogenic mechanism", Anticancer Res, 29(12), 2009, 5103-5109.
73. Villares, G. J., Zigler, M., Wang, H., Melnikova, V. O., Wu, H., Friedman, R., Leslie, M. C., Vivas-Mejia, P. E., Lopez-Berestein, G., Sood, A. K., Bar-Eli, M. "Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA", Cancer Res, 68(1), 2008, 9078-9086.
74. Templeton, A. C., Wuelfing, W. P., Murray, R. W. "Monolayer- protected cluster molecules", Accounts of Chemical Research 33(1), 1999, 27-36.
75. Bhattacharya, R., Mukherjee, P. "Biological properties of 'naked' metal nanoparticles", Advanced Drug Delivery Reviews 60(11), 2008, 1289-1306.
76. Visaria, R. K., Griffin R. J., Williams, B. W., Ebbini, E. S., Paccioti, G. F., Song, C. W., Bischof, J. C. "Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor alpha delivery", Mol Cancer Ther, 5(4), 2006, 1014-20. (Pubitemid 43724602)
77. Chen, Y. H., Tsai, C. Y., Huang, P. Y., Chang, M. Y., Cheng, P. C., Chou, C. S., Chen, D. H., Wang, C.R., Shiau, A. L., Wu, C. L. "Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model", Mol Pharm, 4(5), 2007b, 713-22.
78. Qioa, G., Zhuo, L., Gao, Y., Yu, L., Li, N., Tang, B. "A tumor mRNA-dependent gold nanoparticle-molecular beacon carrier for controlled drug release and intracellular imaging", Chem Commun, 47(26), pp. 7458-60, 2011.
79. Bikram, M., Gobin, A. M., Whitmire, R. E., West, J. L. "Temperature-sensitive hydrogels with SiO2-Au nanoshells for controlled drug delivery", J Control Release, 123(3), 2007, 219-27. (Pubitemid 350007822)
80. Chithrani, B. D., Ghazani, A. A., Chan, W. C. "Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells", Nano Lett, 6(4), 2006, 662-8.
81. Cai W., Gao T., Hong H., Sun Jiangtao. "Application of gold nanoparticles in cancer nanotechnology", Nanotechnology: Science and applications, 2008(1), 17-32.
82. Khan, J. A., Kudgus, R. A., Szabolcs, A., Dutta, S., Wand, E., Cao, S., Curran, G. L., Shah, V., Curley, S., Mukhopadyay, D., Robertson, J. D., Bhattacharya, R., Mukherjee, P. "Designing nanoconjugates to effectively target pancreatic cancer cells in vivo and in vivo", PLos One, 6(6), 2011, e20347.
83. Arvizo, R. R., GiriK, Miranda A. R., Madden, B., McCormick, D. J., Bhattacharya, R., Rotello, V. M., Kocher, J. P., Mukherjeee, P. "Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles", PLoS One, 7(3), 2012, e33650.
84. Lee, P., Zhang, R., Li, V., Liu, X., Sun, R. W., Che, C. M., Wong, K. K. "Enhancement of anticancer efficacy using modified lipophilic nanoparticle drug encapsulation", Int J Nanomedicine, 2012(7), 731-7.
85. Sokolova, V. V., Radtke, I., Heumann, R., Epple, M. "Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles, Biomaterials", 27(16), pp. 3147-3153, 2006. (Pubitemid 43247588)
86. Zhang, X., Kovtun, A., Mendoza-Palomares, C., Oulad-Abdelghani, M., Fioretti, F., Rinckenbach, S., Mainard, D., Epple, M., Benkirane-Jessel, N. "SiRNA-loaded multishell nanoparticles incorporated into a multilayered film as a reservoir for gene silencing", Biomaterials. 31(23), pp. 6013-6018, 2010.
87. Sokolova, V., Kovtun, A., Prymak, O., Meyer-Zaika, W., Kubareva, E. A., Romanova, E. A., Oretskaya, T. S., Heumann, R., Epple, M. " Functionalisation of calcium phosphate nanoparticles by oligonucleotides and their application for gene silencing", J. Mater. Chem. 17(8), pp. 721-727, 2007.
88. Morgan, T. T, Muddana, H. S, Altinoglu, E. I, Rouse, S. M, Tabakovi , A., Tabouillot, T., Russin, T. J., Shanmugavelandy, S. S., Butler, P. J., Eklund, P. C., Yun, J. K., Kester, M., Adair, J. H. "Encapsulation of organic molecules in calcium phosphate nanocomposite particles for intracellular imaging and drug delivery", Nano Lett. 8(12), pp. 4108-4115, 2008.
89. Barroug, A., Kuhn, L. T., Gerstenfeld, L. C., Glimcher, M. J. "Interactions of cisplatin with calcium phosphate nanoparticles: in vivo controlled adsorption and release", J Orthop Res. 22(4), pp. 703-708, 2004. (Pubitemid 38756247)
90. Luo, Y., Ling, Y., Guo, W., Pang, J., Liu, W., Fang, Y., Wen, X., Wei, K., Gao, X. "Docetaxel loaded oleic acidcoated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells", J Control Release. 147(2), pp. 278-288, 2010.
91. Mukesh, U., Kulkarni, V., Tushar, R., Murthy, R. S. "Methotrexate loaded self stabilized calcium phosphate nanoparticles: a novel inorganic carrier for intracellular drug delivery", J Biomed Nanotechnol. 5(1), pp. 99-105, 2009.
92. Lu, J., Liong, M., Zink, J. I., Tamanoi, F. "Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs", Small. 3(8), pp. 1341-1346, 2007. (Pubitemid 47245524)
93. Vallet-Regi, M. "Ordered mesoporous materials in the context of drug delivery systems and bone tissue engineering", Chemistry. 12(23), pp. 5934-5943, 2006. (Pubitemid 44231020)
94. Doadrio, J. C., Sousa, E. M. B., Izquierdo-Barba, I., Doadrio, A. L., Perez-Pariente, J., Vallet-Regi, M. "Functionalization of mesoporous materials with long alkyl chains as a strategy for controlling drug delivery pattern", J. Mater. Chem. 16(5), pp. 462-466, 2006. (Pubitemid 43324441)
95. Balas, F., Manzano, M., Horcajada, P., Vallet-Regi, M. "Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials", J Am Chem Soc. 128(25), pp. 8116-8117, 2006 (Pubitemid 43967738)
96. Liong, M., Lu, J., Kovochich, M., Xia, T., Ruehm, S. G., Nel, A. E., Tamanoi, F., Zink, J. I. "Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery", ACS Nano. 2(5), pp. 889-896, 2008.
97. Hudson, S. P., Padera, R. F., Langer, R., Kohane, D. S. "The biocompatibility of mesoporous silicates", Biomaterials 29(30), pp. 4045-4055, 2008.
98. Lu, J., Liong, M., Li, Z., Zink, J. I., Tamanoi, F. " Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals", Small 6(16), pp. 1794-1805, 2010.
99. Nair, S., Sasidharan, A., Rani, V. V. D., Menon, D., Manzoor, K., Raina, S. "Role of size scale of ZnO nanoparticles and microparticles on toxicity toward bacteria and osteoblast cancer cells", J.Mater. Sci: Mater. Med., 20, pp. S235-S241, 2009.
100. Shen, W., Xiong, H., Cai, S., Lu, H., Yang, P. "ZnOpoly( methyl methacrylate) nanobeads for enriching and desalting low-abundant proteins followed by directly MALDI-TOF MS analysis", Analytical chemistry, 80(17), pp. 6758-63, 2008.
101. Dorfman, A., Parajuli, O., Kumar, N., Hahm, J. I. "Novel telomeric repeat elongation assay performed on zinc oxide nanorod array supports", Journal of nanoscience and nanotechnology, 8(1), pp. 410-5, 2008. (Pubitemid 351594278)
102. Nie, L., Gao, L., Feng, P., Jhang, J., Fu, X., Liu, Y., Yan, X., Wang, T. "Three-dimensional functionalized tetrapodlike ZnO nanostructures for plasmid DNA delivery", Small (Weinheim an der Bergstrasse, Germany), 2(5), pp. 621-5, 2006.
103. Zhang, P. & Liu, W. "ZnO QD@PMAA-co-PDMAEMA nonviral vector for plasmid DNA delivery and bioimaging", Biomaterials, 31(11), pp. 3087-94, 2010.
104. Moos, P. J., Chung, K., Woessnar, D., Honeggar, M., Cuttler, N. S., Veranth, J. M. "ZnO particulate matter requires cell contact for toxicity in human colon cancer cells", Chemical research in toxicology, 23(4), pp. 733-9, 2010.
105. Guo, D., Wu, C., Jiang, H., Li, Q., Wang, X., Chen, B. "Synergistic cytotoxic effect of different sized ZnO nanoparticles and daunorubicin against leukemia cancer cells under UV irradiation", Journal of photochemistry and photobiology. B, Biology, 93(3), pp. 119-26, 2008.
106. Yuan, T. L., Cantley, L. C. "PI3K pathway alterations in cancer: variations on a theme", Oncogene, 27(41), pp. 5497-551, 2008.
107. Sasidharan, A., Chandran, P., Menon, D., Raman, S., Nair, S., Koyakutty, M. "Radpid dissolution of ZnO nanocrystals in acidic cancer micro environment leading to preferential apoptosis", Nanoscale, 3, pp. 3657-69, 2011.
108. Visaria, R. K., Griffin R. J., Williams, B. W., Ebbini, E. S., Paccioti, G. F., Song, C. W., Bischof, J. C. "Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factoralpha delivery", Mol Cancer Ther, 5(4), pp. 1014-20, 2006. (Pubitemid 43724602)
109. Chen, Y., Wan, Y., Wang, Y., Zhang, H., Jiao, Z. "Anti cancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles", Intl J Nanomed. 6, 2011, 2321-2326.
110. Shapira, A., Livney, Y. D., Broxterman, H. J., Assaraf, Y. G. "Nanomedicine for targeted cancer therapy: Towards the overcoming drug resistance", Drug resistance updates, 14, pp. 150-163, 2011.
111. Basu, S., Harfouche, R., Soni, S., Chimote, G., Mashelkar, R. A., Sengupta S. "Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy", Proc Natl Acad Sci USA,106, pp. 7957-7961, 2009.
112. Pinhassi, R. I., Assaraf, Y. G., Farber, S., Stark, M., Ickowicz, D., Drori S., Domb, A. J., Livney, Y. D. "Arabinogalactan-folate-drug conjugate for targeted delivery and target-activated release of anticancer drugs to folate receptorover expressing cells", Biomacromolecules 11(1), pp. 294-303, 2010.
113. Chien, A. J., Illi, J. A., Ko, A. H., Korn, W. M., Fong, L., Chen, L. M. "A Phase I study of a 2-day lapatinib chemosensitization pulse preceding nanoparticle albuminbound paclitaxel for advanced solid malignancies", Clin. Cancer Res. 15(17), pp. 5569-5575, 2009.
114. Conlin, A. K., Seidman, A. D., Bach, A. "Phase II trial of weekly nanoparticle albumin-bound paclitaxel with carboplatin and trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer", Clin. Breast Cancer 10(4), pp. 281-287, 2010.
115. Robidoux, A., Buzdar A. U., Quinaux, E., Jacobs, S., Rastogi, P. "A phase II neoadjuvant trial of sequential nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide in locally advanced breast cancer", Clin. Breast Cancer 10(1), pp. 81-86, 2010.
116. Kwon, I. C. "Theragnostic imaging of tumors by polymer nanoparticle. Nanomed. Nanotechnol", Biol. Med. 3(4), pp. 342-343, 2007.
117. Manning, G., Whyte, D. B., Martinex, R., Hunter, T., Sudarsanam, S. "The Protein Kinase Complement of the Human Genome", Science. 298(5600), 1912-34, 2002. (Pubitemid 35425239)
118. Arora A., Scholar, E. M. "Role of Tyrosine Kinase Inhibitors in Cancer Therapy", J Pharmacol Exp Ther. 315(3), pp. 971-979, 2005. (Pubitemid 41635382)
119. Pawson, T., Warner, N. "Oncogenic re-wiring of cellular signaling pathways", Oncogene. 26(9), 26, pp. 1268-1275, 2007. (Pubitemid 46328468)
120. Fedorov, O., Muller, S.,, Knapp, S. "The (un)targeted cancer kinome", Nat Chem Biol. 6(3), pp. 166-169, 2010
121. Levitzki, A. "Signal Transduction Therapy with Rationally Designed Kinase Inhibitors", Mol Aspects Med. 31(4), 287-329, 2010.
122. Chaubal, M. V., Kipp, J., Rabinow, B. "Excipient Selection and Criteria for Injectable Dosage Forms. Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems, Chapter 16", Informa Healthcare 2006:271-290; doi: 10.1201/9781420004137.ch16
123. Knight, Z. A., Lin, H., Shokath, K. M. "Targeting the cancer kinome through polypharmacology", Nat Rev Cancer. 10(2), pp. 130-7, 2010.
124. Natalie, P. P., Mamdal, P. K. et al. "Engineered Nanoparticles in Cancer Therapy", Recent Patents on Drug Delivery & Formulation 1(1), pp. 37-51, 2007.
125. Diana, C. "Nanoparticle albumin-bound (nab) rapamycin as an anticancer agent", Mol Cancer Ther 9, pp. 963-975, 2010.
126. McCaffrey, A. P., Meuse, L., Pham, T.T, Conklin, D. S., Hannon, G. J., Kay, M. A. "Gene expression: RNA interference in adult mice", Nature, 418, pp. 38-39, 2002. (Pubitemid 34742563)
127. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., Mello, C. C. "Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans", Nature 391, pp. 806-811, 1998. (Pubitemid 28099681)
128. Elbashir, S. M., Lendeckel, W., Tuschl, T. "RNA interference is mediated by 21-and 22-nucleotide RNAs", Genes Dev 15, pp. 188-200, 2001. (Pubitemid 32107664)
129. Rutz, S., Scheffold, A. "Towards in vivo application of RNA interference -new toys, old problems", Arthritis Res Ther, 6(2), pp. 78-85, 2004. (Pubitemid 38444466)
130. Vance, V., Vaucheret, H. "RNA silencing in plants: defense and counter defense", Science, 292(5525), pp. 2277-2280, 292, 2001 (Pubitemid 32568040)
131. Plasterk, R. H. "RNA silencing: the genome's immune system", Science, 296(5571), pp. 1263-1265, 2002. (Pubitemid 34522772)
132. Myers, J. W., Jones, J. T., Meyer, T., Ferrell, J. E. Jr. "Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing", Nat Biotechnol 21(3), pp. 324-328, 2003. (Pubitemid 36314820)
133. Bumcrot, D., Manoharan, M., Koteliansky, V., Sah, D. W. Y. "RNAi therapeutics: a potential new class of pharmaceutical drugs", Nature Chem. Biol. 2, 711-719, 2006. (Pubitemid 44764213)
134. Juliano, R., Bauman, J., Kang, H., Ming, X. "Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides", Molecular Pharmaceutics 6(3), 686-695, 2009.
135. Reischl, D., Zimmer, A. "Drug delivery of siRNA therapeutics: potentials and limits of nanosystems", Nanomedicine: Nanotechnology, Biology, and Medicine. 5, pp. 8-20, 2009.
136. Li, S. D., Huang, L. "Gene therapy progress and prospects: non-viral gene therapy by systemic delivery", Gene Therapy, 13(18), pp. 1313-1319, 2006. (Pubitemid 44323687)
137. Howard, K. A., Rahbek, U. L., Liu, X., Damgaard, C. K., Hovgaard, M. B., Schmitz, A., Nyengaard, J. R., Besenbacher, F., Kjems, J. "RNA Interference in vivo and in vivo Using a Chitosan/siRNA Nanoparticle System", Molecular Therapy, 14 2006.
138. Katas, H., Alpar, H. O. "Development and characterisation of chitosan nanoparticles for siRNA delivery", J Control Release, 115(2), pp. 216-25, 2006. (Pubitemid 44559708)
139. Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher A., Alabi, C. A., Yen, Y., Heide, J. D., Ribas, A. "Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles", Nature, 464, pp. 1067-1070, 2010.
140. Ferrara, N. "VEGF as a therapeutic target in cancer", Oncology, 69(Suppl 3), pp. 11-16, 2005. (Pubitemid 41680948)
141. Chaudhuri, P., Harfouche, R., Soni, S., Hentschel, D. M., Sengupta, S. "Shape effect of carbon nanovectors on angiogenesis", ACS Nano, 4(1), pp. 574-582, 2010.
142. Schiffelers, R. M., Ansari, A., Xu, J., Zhou, Q., Tang, Q., Storm, G., Molema, G., Lu, P. Y., Scaria, P. V., Woodle, M. C. "Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle", Nucleic Acids Res 32(19), 149, 2004.
143. Villares, G. J., Zigler, M., Wang, H., Melnikova ,V. O., Wu, H., Friedman, R., Leslie, M. C., Vivas-Mejia, P. E., Lopez-Berestein, G., Sood, A. K., Bar-Eli, M. "Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA", Cancer Res, 68, pp. 9078-9086, 2008.
144. Pille, J. Y., Li, H., Blot, E., Bertrand, J. R., Pritchard, L. L., Opolon, P., Maksimenko, A., Lu, H., Vannier, J. P., Soria, J., Malvy, C., Soria, C. "Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer", Hum Gene Ther 17(10), pp. 1019-1026, 2006. (Pubitemid 46076743)
145. Carrasquillo, K. G., Ricker, J. A., Rigas, I. K., Miller, J. W., Gragoudas, E. S., Adamis, A. P. "Controlled delivery of the anti-VEGF aptamer EYE001 with poly(lactic-coglycolic) acid microspheres", Invest Ophthalmol Vis Sci, 44(1), pp. 290-299, 2003. (Pubitemid 36134287)
146. Yang, F., Cho, S. W., Son, S. M., Bogatyrev, S. R., Singh, D., Green, J. J., Mei, Y., Park, S., Bhang, S. H., Kim, B. S., Langer, R., Anderson, D. G. "Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles", Proc Natl Acad Sci USA, 107, pp. 3317-3322, 2010.
147. Satchi-Fainaro, R., Puder, M., Davies, J. W., Tran, H. T., Sampson, D. A., Greene, A. K., Corfas, G., Folkman, J. "Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470", Nat Med, 10, pp. 255-261, 2004. (Pubitemid 38667615)
148. Segal, E., Pan, H., Ofek, P., Udagawa, T., Kopeckova, P., Kopecek, J., Satchi-Fainaro, R. "Targeting angiogenesisdependent calcified neoplasms usingcombined polymer therapeutics", PLoS ONE, 4(4), pp. e5233, 2009.
149. Mitra, A., Coleman, T., Borgman, M., Nan, A., Ghandehari, H., Line, B. R. "Polymeric conjugates of monoand bi-cyclic alphaVbeta3 binding peptides for tumor targeting", J Control Release, 114(2), pp. 175-183, 2006. (Pubitemid 44291848)
150. Harfouche, R., Basu, S., Soni, S., M, D., Hentschel, R., Mashelkar, A., Sengupta, S. "Nanoparticle-mediated targeting of phosphatidylinositol-3- kinase signaling inhibits angiogenesis", Angiogenesis, 12(4), pp. 325-338, 2009.
151. Veronese, F. M., Pasut, G. "PEGylation, successful approach to drug delivery", Drug Discov Today, 10(21), pp. 1451-1458, 2005. (Pubitemid 41483874)
152. Xu, Y., Wen, Z., Xu, Z. "Chitosan nanoparticles inhibit the growth of human hepatocellular carcinoma xenografts through an anti angiogenic mechanism", Anticancer Res, 29(12), pp. 5103-5109, 2009.
153. Backer, M. V., Gaynutdinov, T. I., Patel, V., Bandyopadhyaya, A. K., Thirumamagal, B. T., Tjarks, W., Barth, R. F., Claffey, K., Backer, J. M. "Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature", Mol Cancer Ther, 4, pp. 1423-1429, 2005.
154. Benny, O., Fainaru, O., Adini, A., Cassiola, F., Bazinet, L., Adini, I., Pravda, E., Nahmias, Y., Koirala, S., Corfas, G., D'Amato, R. J., Folkman, J. "An orally delivered smallmolecule formulation with anti angiogenic and anticancer activity", Nat Biotechnol, 26, pp. 799-807, 2008. (Pubitemid 351961454)
155. Oku, N., Asai, T., Watanabe, K., Kuromi, K., Nagatsuka, M., Kurohane, K., Kikkawa, H., Ogino, K., Tanaka, M., Ishikawa, D., Tsukada, H., Momose, M., Nakayama, J., Taki, T. "Antineovascular therapy using novel peptides homing to angiogenic Vessels", Oncogene, 21, pp. 2662-2669, 2002. (Pubitemid 34478324)
156. Li, L., Wartchow, C. A., Danthi, S. N., Shen, Z., Dechene, N., Pease, J., Choi, H. S., Doede, T., Chu, P., Ning, S., Lee, D. Y., Bednarski, M. D., Knox, S. J. "A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles", Int J Radiat Oncol Biol Phys, 58(4), pp. 1215-1227, 2004. (Pubitemid 38314807)
157. Hatakeyama, H., Akita, H., Ishida, E., Hashimoto, K., Kobayashi, H., Aoki, T., Yasuda, J., Obata, K., Kikuchi, H., Ishida, T., Kiwada, H., Harashima, H. "Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes", Int J Pharm, 342(1-2), pp. 194-200, 2007. (Pubitemid 47259319)
158. Murugesan, S., Mousa, S. A., O'connor, L. J., Lincoln, D. W., Linhardt, R. J. "Carbon inhibits vascular endothelial growth factor-and fibroblast growth factor promoted angiogenesis", FEBS Lett, 581(6), pp. 1157-1160, 2007. (Pubitemid 46385938)
159. Mukherjee, P., Bhattacharya, R., Wang, P., Wang, L., Basu, S., Nagy, J. A., Atala, A., Mukhopadhyay, D., Soker, S. "Anti angiogenic properties of gold nanoparticles", Clin Cancer Res, 11, pp. 3530-3534, 2005. (Pubitemid 40627908)
160. Eichler, A. F., Chung, E., Kodack, D. P., Loeffler, J. S., Fukumura, D., Jain, R. K. "The biology of brain metastasestranslation to new therapies", Nature Rev. Clin. Oncol. 8, pp. 344-356, 2011.
161. Veiseh, O., Sun, C., Fang, C., Bhattarai, N., Gumn, J., Kievit, F., Du, K., Pullar, B., Lee, D., Ellenbogen, R. G., Olson, J., Zhang, M. "Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier", Cancer Res. 69(15), 2009, 6200-6207.
162. Tassa, C., Shaw, S. Y., Weissleder, R. "Dextran-coated iron oxide nanoparticles: a versatile platform for targeted molecular imaging, molecular diagnostics, and therapy", Acc. Chem. Res. 44(10), pp. 842-852, 2011.
163. Nahrendorf, M., Keliher, E., Marinelli, B., Leuschner, F., Robbins, C. S., Gerszten, R. E., Pittet, M. J., Swirski, F. K., Weissleder, R. "Detection of macrophages in aortic aneurysms by nanoparticle positron emission tomographycomputed tomography. Arterioscler", Thromb. Vasc. Biol. 31, pp. 750-757, 2011.
164. Sadauskas, E., Wallin, H., Stoltenberg, M., Vogel, U., Doering, P., Larsen, A., Danscher, G. et al. "Kupffer cells are central in the removal of nanoparticles from the organism", Part. Fibre Toxicol. 4, pp. 10, 2007.
165. Cervantes, A., Alsina, J., Tabernero, J. R., Infante, J. R., LoRusso, P., Shapiro, G., Paz-Ares, L. G., Falzone, R., Hill, J., Cehelsky, J., White, A., Toudjarska, I., Bumcrot, R., Meyers,R., Hinkle, G., Svrzikapa, N., Sah, D. W., Vaishnaw, A., Gollob, J., Burris, H. A. "Phase I dose-escalation study of ALN-VSP02, a novel RNAi therapeutic for solid tumors with liver involvement", J. Clin. Oncol. Abstr. 29, 3025, 2011.
166. Chertok, B., David, A. E., Yang, V. C. "Brain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topography", J. Control. Release, 155(3), 393-399, 2011.
167. Jain, R. K., Lee, J. J., Hong, D., Markaman, M., Gong, J., Naing, A., Wheler, J., Kurzrock, R. "Phase I oncology studies: evidence that in the era of targeted therapies patients on lower doses do not fare worse", Clin. Cancer Res. 16(4), pp. 1289-1297, 2010.
168. Desgrosellier, J. S., Cheresh, D. A. "Integrins in cancer: biological implications and therapeutic opportunities", Nature Rev. Cancer 10, pp. 9-22, 2010.
169. Wang, X., Jun, L., Wang,Y., Koenig, L., Gjyrez, A., Giannakakou, P., Shin, E. H., Tighiouart, M., Chen, Z., Nie, S., Shin, D. M. "A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model", ACS Nano, 5(8), pp. 6184-6194, 2011.
170. Rand, R. W., Snow, H. D., Elliot, D. G., Haskins, G. "Induction heating method for use in causing necrosis of neoplasm", US Patent Specification 4(545), pp. 368, 1985.
171. Manthe, R. L., Foy, S. P., Krishnamurthy, N., Sharma, B., Labhasetwar, V. "Tumor ablation and nanotechnology", Molecular Pharmaceutics, 7(6), pp. 1880-1898, 2010.
172. McTaggart, R. A., Dupuy, D. E. "Thermal ablation of lung tumors", Tech. Vasc. Interv. Radiol. 10, pp. 102-113, 2007. (Pubitemid 350216511)
173. Aharroni, A. "Introduction to the theory of Ferromagnetism", Oxford: Clarendon.
174. Hergt, R., Dutz, S., Muller, R., Zeisberger, M. "Magnetic particle hyperthermia: nanoparticle magnetism and materials development for cancer therapy", J. Phys: Condens. Matter 18, pp. S2919-S2934, 2006. (Pubitemid 44523010)
175. Johannsen, M., Gneveckow, U., Eckelt, L., Feussner, A., Waldofner, N., Scholz, R., Deger, S., Wust, P., Loening, S. A., Jordan, A. "Clinical Hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique", Int. J. Hyperthermia, 21(7), pp. 637-647, 2005. (Pubitemid 41684238)
176. Maier-Hauff, K., Rothe, R., Scholz, R., Gneveckow, U., Wust, P., Thiesen B., Feussner, A., Von Deimling, A., Waldofner, N., Felix, R., Jordan, A. "Intracranial thermo therapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme", J. Neuro-Oncol., 81(1), pp. 53-60, 2007. (Pubitemid 44963989)
177. Mohammad, F., Balaji, G., Weber, A., Uppu, R. M., Kumar, C. S. S. R. "Influence of Gold nanoshell on hyperthermia of super paramagnetic iron oxide nanoparticles (SPIONs)", J. Phys. Chem. C Nanomater. Interfaces; 1(20), pp. 3141-3146, 2010.
178. Yu, H., Chen, M., Rice, P. M., Wang, S. X., White, R. L., Sun, S. "Dumbbell-like bifunctional Au-Fe3O4 nanoparticles", Nano Lett. 5, pp. 379, 2005.
179. Frey, N. A., Srinath, S., Srikanth, H., Chao, T., Sun, S. "Static and Dynamic Magnetic Properties of Composite Au-Fe3O4 Nanoparticles", IEEE Trans Magn. 43, pp. 3094, 2007.
180. Morales, M. P., Veintemillas-Verdaguer, S., Montero, M. I., Serna, C. J., Roig, A., Martinez, B., Casas, L., Sandiumenge, F. "Surface and Internal Spin Canting in -Fe2O3 Nanoparticles", Chem. Mater. 11, pp. 3058, 1999.
181. Li, D., Jung, Y. S., Tan, S., Kim, H. K., Chory, E., Geller, D. A. "Negligible absorption of radiofrequency radiation by colloidal gold nanoparticles", J. Colloidal and Interface Sci. 358, pp. 47-53, 2011.
182. Day, E. S., Bickford, L. R., Slater, J. H., Riggall, N. S., Drezek, R. A., West, J. L. "Antibody-conjugated gold-gold sulphide nanoparticles as multifunctional agents for imaging and therapy of breast cancer", 5, pp. 445-454, 2010.
183. O'Neal, P. D., Hirsch, L. R., Halas, N. J., Payne, J. D., West, K. L. "Photothermal tumor ablation in mice using near-infrared absorbing nanoparticles", Cancer let. 209, pp. 171-176, 2004. (Pubitemid 38670486)
184. Tong, L., Zhao, Y., Huff, T. B., Hansen, M. N., Wei, A., Chen. J. "Gold nanorods mediate tumor cell death by compromising membrane integrity", Adv. Mater., 19, pp. 3136-3141, 2007. (Pubitemid 350044449)
185. Kennedy, L. C., Bickford, L. R., Lewinski, N. A., Coughlin, A. J., Hu. Y., Day, E. S., West, J. L., Drezek, R. A. "A new era for cancer treatment: Gold nanoparticle mediated thermal therapies", Small, 7(2), pp. 169-183, 2011.
186. Goldberg, S. N. "Radiofrequency tumor ablation: Principles and Techniques", Euro. J. Ultrasound, 13, pp. 129-147, 2001. (Pubitemid 32463283)
187. Cherukuri, P., Glazer, E. S., Curley, S. A. "Targetted hyperthermia using metal nanoparticles", Adv Drug Del. Rev, 62, pp. 339-342, 2010.
188. Curley, S. A. "Radiofrequency ablation of malignant liver tumors", Ann. Surg. Oncol., 10, pp. 338-347, 2003. (Pubitemid 40486929)
189. Curley, S. A., Izzo, F., Ellis, L. M., Vauthey, N., Vallone. P. "Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis", Ann. Surg., 232, pp. 381-391, 2000.
190. Gannon, C. J., Cherkuri, P., Yakobson, B. I., Cognet, L., Kanzius, J. S., Kittrell, C., Weisman, R. B., Pasquali, M., Schmidt, H. K., Smalley, R. E., Curley, S. A. "Carbon nanotube enhanced thermal destruction of cancer cells in a non-invasive radiofrequency field", Cancer, 110(12), pp. 2654-2665, 2007. (Pubitemid 350250334)
191. Day, E. S., Morton, J. G., West, J. L. "Nanoparticles for thermal cancer therapy", J. Biomechanical Eng., 131, pp. 1-5, 2009.